This kind of oligomer, containing the peptide ligand cMBP2 binding to hepatocyte growth factor receptor/c-Met, showed enhanced gene delivery efficacy and target-specificity in vitro in HUH7 hepatoma and DU145 prostate carcinoma. Here, MET is linked to prostate carcinoma.